Work

Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Year: 2018
Type: article
Abstract: β-cell replacement therapy, available currently as pancreas or islet transplantation, has developed without a clear definition of graft functional and clinical outcomes.The International Pancreas & Islet Transplant Association (IPITA) and European Pancreas & Islet Transplantation Association (EPITA) held a workshop to develop consensus for an IPITA/EPITA Statement on the definition of function and failure of current and future forms of β-cell replacement therapy.There was consensus that β-cell replacement therapy could be considered as a treatment for β-cell failure, regardless of etiology and without requiring undetectable C-peptide, accompanied by glycemic instability with either problematic hypoglycemia or hyperglycemia.Glycemic control should be assessed at a minimum by glycated hemoglobin (HbA 1c ) and the occurrence of severe hypoglycemia.Optimal β-cell graft function is defined by near-normal glycemic control (HbA 1c ≤6.5% [48 mmol/mol]) without severe hypoglycemia or requirement for insulin or other antihyperglycemic therapy, and with an increase over pretransplant measurement of C-peptide.Good β-cell graft function requires HbA 1c <7.0% (53 mmol/mol) without severe hypoglycemia and with a significant (>50%) reduction in insulin requirements and restoration of clinically significant C-peptide production.Marginal β-cell graft function is defined by failure to achieve HbA 1c <7.0% (53 mmol/mol), the occurrence of any severe hypoglycemia, or less than 50% reduction in insulin requirements when there is restoration of clinically significant C-peptide production documented by improvement in hypoglycemia awareness/severity, or glycemic variability/lability.A failed β-cell graft is defined by the absence of any evidence for clinically significant C-peptide production.Optimal and good function are considered successful clinical outcomes.
Authors: Rickels, M.R., Stock, P.G., Koning, E.J.P. de, Piemonti, L., Pratschke, J., Alejandro, R., Bellin, M.D., Berney, T., Choudhary, P., Johnson, P.R., Kandaswamy, R., Kay, T.W.H., Keymeulen, B., Kudva, Y.C., Latres, E., Langer, R.M., Lehmann, R., Ludwig, B., Markmann, J.F., Marinac, M., Odorico, J.S., Pattou, F., Senior, P.A., Shaw, J.A.M., Vantyghem, M.C., White, S.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7008902659
FWCI:
Cites: 30
Cited by: 2
Related to: 9